CDC Anthrax Researcher Resigns

The former head of a US Centers for Disease Control and Prevention biosecurity lab has left his post amidst safety retooling at government labs.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDCMichael Farrell, the former head of the US Centers for Disease Control and Prevention (CDC) Bioterror Rapid Response and Advanced Technology Laboratory, who last month was reassigned in the wake of the biosecurity oversight that exposed agency scientists to anthrax, has now resigned. CDC spokesperson Thomas Skinner told The New York Times that Farrell’s resignation was voluntary. “It was his decision,” Skinner said.

Farrell led the Bioterror Rapid Response and Advanced Technology Laboratory, which handles potentially dangerous materials including pathogens like Bacillus anthracis, since 2009. As The Guardian pointed out, Farrell is the first government employee to leave his post following a string of lab safety mishaps that have led to increased scrutiny.

In media interviews, Sean Kaufman, a former CDC employee who’s now president of the consulting firm Behavioral-Based Improvement Solutions, defended Farrell. “He’s a scapegoat and everybody knows that,” Kaufman, who was asked to testify at last week’s House hearing on biosecurity issues in government labs, told USA Today. “For [Farrell] to resign as a result of this is an indicator that they’re focusing on who instead of what. It was a culture that led to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies